Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients

Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients

10.1046/j.1365-2036.2002.01364.x

Saved in:

書目詳細資料
Main Authors:	Lim, L.L., Wai, C.T., Lee, Y.M., Kong, H.L., Lim, R., Koay, E., Lim, S.G.
其他作者:	MEDICINE
格式:	Article
出版:	2016
在線閱讀:	http://scholarbank.nus.edu.sg/handle/10635/131387
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Outcome of lamivudine resistant hepatitis B virus infection in liver transplant recipients in Singapore [4]
由: Wai, C.T., et al.
出版: (2016)

Prophylactic strategies for Hepatitis B patients undergoing liver transplant: A cost-effectiveness analysis
由: Dan, Y.Y., et al.
出版: (2011)

Outcome of lamivudine resistant hepatitis B virus infection in liver transplant recipients in Singapore [7] (multiple letters)
由: Wai, C.T., et al.
出版: (2014)

Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B
由: Lim, S.G., et al.
出版: (2014)

Outcome of lamivudine-resistant hepatitis B virus is generally benign except in cirrhotics
由: Dan, Y.-Y., et al.
出版: (2016)

Four years of lamivudine treatment in Chinese patients with chronic hepatitis B
由: Chang, T.-T., et al.
出版: (2016)

Telbivudine versus lamivudine in patients with chronic hepatitis B
由: Ching Lung Lai, et al.
出版: (2018)

Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant
由: Wai, C.-T., et al.
出版: (2011)

Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents
由: Aurpibul L., et al.
出版: (2017)

Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours
由: Ling, W.H.Y., et al.
出版: (2014)

Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus
由: Beck I., et al.
出版: (2017)

Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents
由: Linda Aurpibul, et al.
出版: (2018)

Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents
由: Linda Aurpibul, et al.
出版: (2018)

Prevention of hepatocellular carcinoma in hepatitis B virus infection
由: Lim, S.G., et al.
出版: (2011)

Low Rate of Long-term Virological Suppression in Chronic Hepatitis B Patients Treated with Lamivudine
由: Supot Nimanong, et al.
出版: (2020)

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
由: Lau G.K.K., et al.
出版: (2014)

Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus
由: Ingrid A. Beck, et al.
出版: (2018)

Cataract progression after prophylactic laser peripheral iridotomy: Potential implications for the prevention of glaucoma blindness
由: Lim, L.S., et al.
出版: (2011)

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
由: George K.K. Lau, et al.
出版: (2018)

Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy
由: Pawinee Wongprasit, et al.
出版: (2018)

A prophylactic approach for bone marrow transplantation from a hepatitis B surface antigen-positive donor
由: Abhasnee Sobhonslidsuk, et al.
出版: (2018)

Telbivudine: A hepatitis B-specific antiviral
由: Lim, S.G.
出版: (2011)

Heplisav™: A new hepatitis B vaccine
由: Lim, S.G.
出版: (2011)

Lamivudine Switching after Undetectable HBV DNA is Associated with High Rate of Virological Rebound in Entecavir-treated Chronic Hepatitis B Patients
由: S. Chainuvati, et al.
出版: (2020)

Bladder catheterization increases susceptibility to infection that can be prevented by prophylactic antibiotic treatment
由: Rousseau, Matthieu, et al.
出版: (2017)

Risk for de novo hepatitis B from antibody to hepatitis B core antigen-positive donors in liver transplantation in Singapore
由: Lee, K.H., et al.
出版: (2011)

The majority of hepatitis B carriers are not on regular surveillance in Singapore
由: Wai, C.-T., et al.
出版: (2014)

Role of prophylactic oophorectomy at the time of hysterectomy in ovarian cancer prevention in Thailand
由: Charoenkwan K., et al.
出版: (2014)

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
由: Marcellin, P., et al.
出版: (2014)

Evaluation of one-year lamivudine and telbivudine therapy on chronic hepatitis b patients: Based on biochemical, virological and fibrosis status in dr. soetomo general hospital
由: Ummi Maimunah, et al.
出版: (2019)

Long-term hepatitis B virus (HBV) response to Lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand
由: Khamduang W., et al.
出版: (2014)

Long-term hepatitis B virus (HBV) response to Lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand
由: Woottichai Khamduang, et al.
出版: (2018)

Evaluation of one year lamivudine and telbivudine therapy on chronic hepatitis b patient: Based on biochemical, virological and fibrosis status in dr. soetomo general hospital
由: Ummi Maimunah, et al.
出版: (2019)

Prophylactic oophorectomy: A continuing controversy
由: Fong, Y.-F., et al.
出版: (2016)

Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma.
由: Zhang, D., et al.
出版: (2012)

Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group
由: Kim, S.J., et al.
出版: (2016)

Effectiveness of prophylactic clipping in preventing postpolypectomy bleeding in oral anticoagulant users: a propensity-score analysis
由: Lau, Louis H. S., et al.
出版: (2022)

False-positive HIV-1 ELISA in patients with hepatitis B [1]
由: Wai, C.T., et al.
出版: (2016)

How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore
由: Ong, S.C., et al.
出版: (2014)

Tenofovir versus placebo to prevent perinatal transmission of hepatitis B
由: G. Jourdain, et al.
出版: (2018)